| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |